首页 | 本学科首页   官方微博 | 高级检索  
     

不同剂量血脂康对2型糖尿病合并高血脂症患者血脂水平及炎症因子的影响
引用本文:江洪. 不同剂量血脂康对2型糖尿病合并高血脂症患者血脂水平及炎症因子的影响[J]. 现代中西医结合杂志, 2010, 19(4): 393-394,412
作者姓名:江洪
作者单位:广西田阳县人民医院,广西,田阳,533600
摘    要:目的比较不同剂量血脂康对2型糖尿病合并高血脂症患者血脂水平及炎症因子的影响。方法将90例2型糖尿病合并高血脂症患者随机分为血脂康1.2 g/d组、血脂康2.4 g/d组和普伐他汀20 mg/d组,每组30例,测定治疗前、治疗8周后各组血脂水平及血清高敏C反应蛋白(hs-CRP)、白细胞介素-6(IL-6)水平。结果治疗8周后,3组TC、LDL-C、TG水平均降低,3组间比较无显著性差异;3组血清hs-CRP、IL-6水平均降低。组间比较,hs-CRP、IL-6水平血脂康1.2 g/d组和血脂康2.4 g/d组较普伐他汀20 mg/d组降低明显,血脂康2.4 g/d组较血脂康1.2 g/d组降低明显。结论2型糖尿病合并高脂血症患者早期给予血脂康1.2 g/d和血脂康2.4 g/d调脂作用与普伐他汀20 mg/d无明显差异,但降低炎症因子作用强于普伐他汀20 mg/d。血脂康2.4 g/d降低炎症因子作用最强。

关 键 词:血脂康  2型糖尿病  高血脂症

Effects of different dose of Xuezhikang on blood lipids and inflammatory factors in patients with type 2 diabetes complicating with hyperlipemia
Jiang Hong. Effects of different dose of Xuezhikang on blood lipids and inflammatory factors in patients with type 2 diabetes complicating with hyperlipemia[J]. Modern Journal of Integrated Chinese Traditional and Western Medicine, 2010, 19(4): 393-394,412
Authors:Jiang Hong
Affiliation:Jiang Hong(The People's Hospital of Tianyang County,Tianyang 533600,Guangxi,China)
Abstract:Objective It is to compare the effects of different dose of Xuezhikang on blood lipids and inflammatory factors in patients with type 2 diabetes complicating with hyperlipemia.Methods 90 patients with type 2 diabetes complicating with hyperlipemia were randomly divided into Xuezhikang 1.2 g/d group,Xuezhikang 2.4 g/d group and provastatin 20 mg/d group.There were 30 patients in each group.The level of blood lipids and inflammatory factors including hs-CRP and IL-6 were detected before and after 8 week's tre...
Keywords:Xuezhikang  type 2 diabetes  hyperlipemia  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号